𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bis{4-bromo-2-[3-(dimethyl­amino)propyl­imino­meth­yl]phenolato}nickel(II)

✍ Scribed by Li, Li-Zhong ;Wang, Li-Hua

Publisher
International Union of Crystallography
Year
2007
Tongue
English
Weight
165 KB
Volume
63
Category
Article
ISSN
1600-5368

No coin nor oath required. For personal study only.

✦ Synopsis

The title compound, [Ni(C~12~H~16~BrN~2~O)~2~], crystallizes with two half-molecules per asymmetric unit; each mononuclear molecule is centrosymmetric. The Ni^II^ atom in each molecule, lying on an inversion centre, is six-coordinated in a slightly distorted octahedral geometry by two phenolate O atoms, two imine N atoms and two amine N atoms from two Schiff base ligands.

📜 SIMILAR VOLUMES

Dibromo­{4-bromo-2-[(3-dimethyl­amino­pr
Dibromo­{4-bromo-2-[(3-dimethyl­amino­propyl­imino)meth­yl]phenolato}zinc(II)
✍ Peng, San-Jun ;Hou, Hai-Yun 📂 Article 📅 2006 🏛 International Union of Crystallography 🌐 English ⚖ 247 KB

In the title mononuclear zinc(II) complex, [ZnBr 2 (C 12 H 17 -BrN 2 O)], the Zn II atom is four-coordinated by the imine N and phenolate O atoms of the Schiff base ligand, and by two Br atoms, forming a tetrahedral geometry. In the crystal structure, the molecules are linked through intermolecular

Bis[4-bromo-2-(cyclo­propyl­imino­meth­y
Bis[4-bromo-2-(cyclo­propyl­imino­meth­yl)phenolato]zinc(II)
✍ You, Zhong-Lu 📂 Article 📅 2005 🏛 International Union of Crystallography 🌐 English ⚖ 100 KB

In the mononuclear title complex, [Zn(C 10 H 9 BrNO) 2 ], the Zn II atom is four-coordinated by two imine N and two phenolate O atoms from two Schiff base ligands in a distorted tetrahedral geometry.

Bis[2-(cyclo­propyl­imino­meth­yl)-4-nit
Bis[2-(cyclo­propyl­imino­meth­yl)-4-nitro­phenolato]zinc(II)
✍ You, Zhong-Lu 📂 Article 📅 2005 🏛 International Union of Crystallography 🌐 English ⚖ 264 KB

In the title compound, [Zn(C 10 H 9 N 2 O 3 ) 2 ], the Zn II centre displays a distorted tetrahedral configuration defined by two imine N and two phenolate O atoms from two Schiff base ligands.